| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Microbiology and Immunology, University of Maryland, Baltimore, School of Medicine, Baltimore, MD 21201;
Laboratory of Mycobacterial Diseases and Cellular Immunology, Division of Bacterial, Allergenic, and Parasitic Products, Center for Biologics Evaluation and Research/Food and Drug Administration, Bethesda, MD 20852;
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294;
Department of Basic Medical Science and/or Surgery, Shock/Trauma Research Center, University of Missouri-Kansas City, School of Medicine, Kansas City, MO 64108; and
¶ List Biological Laboratories, Campbell, CA 95008
Francisella tularensis (Ft), a Gram-negative intracellular bacterium, is the etiologic agent of tularemia. Although attenuated for humans, i.p. infection of mice with <10 Ft live vaccine strain (LVS) organisms causes lethal infection that resembles human tularemia, whereas the LD50 for an intradermal infection is >106 organisms. To examine the immunological consequences of Ft LVS infection on the innate immune response, the inflammatory responses of mice infected i.p. or intradermally were compared. Mice infected i.p. displayed greater bacterial burden and increased expression of proinflammatory genes, particularly in the liver. In contrast to most LPS, highly purified Ft LVS LPS (10 µg/ml) was found to be only minimally stimulatory in primary murine macrophages and in HEK293T cells transiently transfected with TLR4/MD-2/CD14, whereas live Ft LVS bacteria were highly stimulatory for macrophages and TLR2-expressing HEK293T cells. Despite the poor stimulatory activity of Ft LVS LPS in vitro, administration of 100 ng of Ft LVS LPS 2 days before Ft LVS challenge severely limited both bacterial burden and cytokine mRNA and protein expression in the absence of detectable Ab at the time of bacterial challenge, yet these mice developed a robust IgM Ab response within 2 days of infection and survived. These data suggest that prior administration of Ft LVS LPS protects the host by diminishing bacterial burden and blunting an otherwise overwhelming inflammatory response, while priming the adaptive immune response for development of a strong Ab response.
This article has been cited by other articles:
|
|
 |
|
  J. R. Wickstrum, S. M. Bokhari, J. L. Fischer, D. M. Pinson, H.-W. Yeh, R. T. Horvat, and M. J. Parmely Francisella tularensis Induces Extensive Caspase-3 Activation and Apoptotic Cell Death in the Tissues of Infected Mice Infect. Immun., November 1, 2009; 77(11): 4827 - 4836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Cole, Y. Yang, K. L. Elkins, E. T. Fernandez, N. Qureshi, M. J. Shlomchik, L. A. Herzenberg, L. A. Herzenberg, and S. N. Vogel Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge PNAS, March 17, 2009; 106(11): 4343 - 4348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. N. Vojtech, G. E. Sanders, C. Conway, V. Ostland, and J. D. Hansen Host Immune Response and Acute Disease in a Zebrafish Model of Francisella Pathogenesis Infect. Immun., February 1, 2009; 77(2): 914 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Hodgkinson, R. C. Laxton, K. Patel, and S. Ye Advanced Glycation End-Product of Low Density Lipoprotein Activates the Toll-Like 4 Receptor Pathway Implications for Diabetic Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2275 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. O. Hazlett, S. D. Caldon, D. G. McArthur, K. A. Cirillo, G. S. Kirimanjeswara, M. L. Magguilli, M. Malik, A. Shah, S. Broderick, I. Golovliov, et al. Adaptation of Francisella tularensis to the Mammalian Environment Is Governed by Cues Which Can Be Mimicked In Vitro Infect. Immun., October 1, 2008; 76(10): 4479 - 4488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Shirey, L. E. Cole, A. D. Keegan, and S. N. Vogel Francisella tularensis Live Vaccine Strain Induces Macrophage Alternative Activation as a Survival Mechanism J. Immunol., September 15, 2008; 181(6): 4159 - 4167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. De Pascalis, B. C. Taylor, and K. L. Elkins Diverse Myeloid and Lymphoid Cell Subpopulations Produce Gamma Interferon during Early Innate Immune Responses to Francisella tularensis Live Vaccine Strain Infect. Immun., September 1, 2008; 76(9): 4311 - 4321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chiavolini, S. Weir, J. R. Murphy, and L. M. Wetzler Neisseria meningitidis PorB, a Toll-Like Receptor 2 Ligand, Improves the Capacity of Francisella tularensis Lipopolysaccharide To Protect Mice against Experimental Tularemia Clin. Vaccine Immunol., September 1, 2008; 15(9): 1322 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Huntley, P. G. Conley, D. A. Rasko, K. E. Hagman, M. A. Apicella, and M. V. Norgard Native Outer Membrane Proteins Protect Mice against Pulmonary Challenge with Virulent Type A Francisella tularensis Infect. Immun., August 1, 2008; 76(8): 3664 - 3671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ben Nasr and G. R. Klimpel Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis J. Leukoc. Biol., July 1, 2008; 84(1): 77 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Cole, A. Santiago, E. Barry, T. J. Kang, K. A. Shirey, Z. J. Roberts, K. L. Elkins, A. S. Cross, and S. N. Vogel Macrophage Proinflammatory Response to Francisella tularensis Live Vaccine Strain Requires Coordination of Multiple Signaling Pathways J. Immunol., May 15, 2008; 180(10): 6885 - 6891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Bokhari, K.-J. Kim, D. M. Pinson, J. Slusser, H.-W. Yeh, and M. J. Parmely NK Cells and Gamma Interferon Coordinate the Formation and Function of Hepatic Granulomas in Mice Infected with the Francisella tularensis Live Vaccine Strain Infect. Immun., April 1, 2008; 76(4): 1379 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chiavolini, J. Alroy, C. A. King, P. Jorth, S. Weir, G. Madico, J. R. Murphy, and L. M. Wetzler Identification of Immunologic and Pathologic Parameters of Death versus Survival in Respiratory Tularemia Infect. Immun., February 1, 2008; 76(2): 486 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-J. Hong, J. R. Wickstrum, H.-W. Yeh, and M. J. Parmely Toll-Like Receptor 2 Controls the Gamma Interferon Response to Francisella tularensis by Mouse Liver Lymphocytes Infect. Immun., November 1, 2007; 75(11): 5338 - 5345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Rahhal, T. J. Vanden Bush, M. K. McLendon, M. A. Apicella, and G. A. Bishop Differential effects of Francisella tularensis lipopolysaccharide on B lymphocytes J. Leukoc. Biol., October 1, 2007; 82(4): 813 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Guina, D. Radulovic, A. J. Bahrami, D. L. Bolton, L. Rohmer, K. A. Jones-Isaac, J. Chen, L. A. Gallagher, B. Gallis, S. Ryu, et al. MglA Regulates Francisella tularensis subsp. novicida (Francisella novicida) Response to Starvation and Oxidative Stress J. Bacteriol., September 15, 2007; 189(18): 6580 - 6586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, C. Ryder, M. Mandal, F. Ahmed, P. Azadi, D. S. Snyder, R. D. Pechous, T. Zahrt, and T. J. Inzana Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS Microbiology, September 1, 2007; 153(9): 3141 - 3153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Cole, K. A. Shirey, E. Barry, A. Santiago, P. Rallabhandi, K. L. Elkins, A. C. Puche, S. M. Michalek, and S. N. Vogel Toll-Like Receptor 2-Mediated Signaling Requirements for Francisella tularensis Live Vaccine Strain Infection of Murine Macrophages Infect. Immun., August 1, 2007; 75(8): 4127 - 4137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. KuoLee, X. Zhao, J. Austin, G. Harris, J. W. Conlan, and W. Chen Mouse Model of Oral Infection with Virulent Type A Francisella tularensis Infect. Immun., April 1, 2007; 75(4): 1651 - 1660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Wickstrum, K.-J. Hong, S. Bokhari, N. Reed, N. McWilliams, R. T. Horvat, and M. J. Parmely Coactivating Signals for the Hepatic Lymphocyte Gamma Interferon Response to Francisella tularensis Infect. Immun., March 1, 2007; 75(3): 1335 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Hajjar, M. D. Harvey, S. A. Shaffer, D. R. Goodlett, A. Sjostedt, H. Edebro, M. Forsman, M. Bystrom, M. Pelletier, C. B. Wilson, et al. Lack of In Vitro and In Vivo Recognition of Francisella tularensis Subspecies Lipopolysaccharide by Toll-Like Receptors Infect. Immun., December 1, 2006; 74(12): 6730 - 6738. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
